Viruses as therapeutic agents. I. Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence

doi:10.1084/jem.171.6.2077

This Article

Full Text (PDF, 943K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Oldstone, M. B.

Search for Related Content

PubMed

PubMed Citation

Articles by Oldstone, M. B.

Pubmed/NCBI databases

Medline Plus Health Information
Compound via MeSH
Substance via MeSH
Diabetes Type 1

Social Bookmarking

What's this?

ARTICLES

Viruses as therapeutic agents. I. Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence

MB Oldstone
Department of Neuropharmacology, Research Institute of Stripps Clinic, La Jolla, California 92037.

A situation in which virus can be used as a therapeutic agent to prevent a lethal autoimmune disease is explored. Nonobese insulin- dependent diabetes (NOD) mice spontaneously develop insulin-dependent diabetes mellitus (IDDM), characterized by lymphocytic infiltration into the islets of Langerhans and beta cell destruction, resulting in hypoinsulinemia, hyperglycemia, ketoacidosis, and death. Infection of NOD mice with lymphocytic choriomeningitis virus (LCMV) aborts the autoimmune manifestations and resultant IDDM. The viruses' effect is on a subset of CD4+ lymphocytes. Ablating this autoimmune diabetes does not significantly alter immune responses to a variety of non-LCMV antigens that require CD4+ lymphocyte participation. The prevention of IDDM associated with viral therapy is maintained throughout the life spans of NOD mice.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Blankenhorn, E. P., Cort, L., Greiner, D. L., Guberski, D. L., Mordes, J. P. (2009). Virus-Induced Autoimmune Diabetes in the LEW.1WR1 Rat Requires Iddm14 and a Genetic Locus Proximal to the Major Histocompatibility Complex. Diabetes 58: 2930-2938 [Abstract] [Full Text]
Alyanakian, M.-A., Grela, F., Aumeunier, A., Chiavaroli, C., Gouarin, C., Bardel, E., Normier, G., Chatenoud, L., Thieblemont, N., Bach, J.-F. (2006). Transforming Growth Factor-{beta} and Natural Killer T-Cells Are Involved in the Protective Effect of a Bacterial Extract on Type 1 Diabetes. Diabetes 55: 179-185 [Abstract] [Full Text]
Christen, U., von Herrath, M. G. (2005). Infections and Autoimmunity--Good or Bad?. J. Immunol. 174: 7481-7486 [Abstract] [Full Text]
Mahamed, D. A., Marleau, A., Alnaeeli, M., Singh, B., Zhang, X., Penninger, J. M., Teng, Y.-T. A. (2005). G(-) Anaerobes-Reactive CD4+ T-Cells Trigger RANKL-Mediated Enhanced Alveolar Bone Loss in Diabetic NOD Mice. Diabetes 54: 1477-1486 [Abstract] [Full Text]
Zipris, D., Lien, E., Xie, J. X., Greiner, D. L., Mordes, J. P., Rossini, A. A. (2005). TLR Activation Synergizes with Kilham Rat Virus Infection to Induce Diabetes in BBDR Rats. J. Immunol. 174: 131-142 [Abstract] [Full Text]
Quintana, F. J., Hagedorn, P. H., Elizur, G., Merbl, Y., Domany, E., Cohen, I. R. (2004). Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc. Natl. Acad. Sci. USA 101: 14615-14621 [Abstract] [Full Text]
Zipris, D., Hillebrands, J.-L., Welsh, R. M., Rozing, J., Xie, J. X., Mordes, J. P., Greiner, D. L., Rossini, A. A. (2003). Infections That Induce Autoimmune Diabetes in BBDR Rats Modulate CD4+CD25+ T Cell Populations. J. Immunol. 170: 3592-3602 [Abstract] [Full Text]
Quintana, F. J., Carmi, P., Cohen, I. R. (2002). DNA Vaccination with Heat Shock Protein 60 Inhibits Cyclophosphamide-Accelerated Diabetes. J. Immunol. 169: 6030-6035 [Abstract] [Full Text]